| REVIEW ARTICLE |
|
| Year : 2014 | Volume
: 6
| Issue : 2 | Page : 71-76 |
|
|
Glycemic management after antenatal corticosteroid therapy
Sanjay Kalra1, Bharti Kalra2, Yashdeep Gupta3
1 Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India
2 Department of Obstetrics and Gynecology, Bharti Hospital, Karnal, Haryana, India
3 Department of Medicine, Government Medical College and Hospital, Chandigarh, India
Correspondence Address:
Sanjay Kalra
Department of Endocrinology, Bharti Hospital, Kunjpura Road, Karnal, Haryana -132 001
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1947-2714.127744
|
|
|
Antenatal corticosteroids (ACS) are recommended for use in antenatal mothers at risk of preterm delivery before 34 weeks. One common side-effect of these drugs is their propensity to cause hyperglycemia. A PubMed search was made using terms 'steroid,' 'dexamethasone,' 'betamethasone' with diabetes/glucose. Relevant articles were extracted. In addition, important cross-reference articles were reviewed. This review, based upon this literature search, discusses the available evidence on effects on glycemic status as well as management strategies in women with pre-existing diabetes, gestational diabetes mellitus, as well as normoglycemic women after ACS use in pregnancy. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
